Abstract
Liver diseases afflict more than 10% of the world population. Although the main risk factors are known and the population at risk is monitored, new biomarkers are urgently needed to allow early diagnosis and hence more effective therapeutic interventions. Here, we revise the contribution of proteomics to the study of liver diseases and its potential impact in the clinical practice is evaluated.
Keywords: Proteomics, mass spectrometry, liver diseases, biomarkers
Mini-Reviews in Medicinal Chemistry
Title: Proteomic Analysis of Liver Diseases: Molecular Mechanisms and Biomarker Discovery
Volume: 8 Issue: 1
Author(s): Fernando J. Corrales, Enrique Santamaria, Javier Munoz, Joaquin Fernandez-Irigoyen, Laura Sesma and Leticia Odriozola
Affiliation:
Keywords: Proteomics, mass spectrometry, liver diseases, biomarkers
Abstract: Liver diseases afflict more than 10% of the world population. Although the main risk factors are known and the population at risk is monitored, new biomarkers are urgently needed to allow early diagnosis and hence more effective therapeutic interventions. Here, we revise the contribution of proteomics to the study of liver diseases and its potential impact in the clinical practice is evaluated.
Export Options
About this article
Cite this article as:
Corrales J. Fernando, Santamaria Enrique, Munoz Javier, Fernandez-Irigoyen Joaquin, Sesma Laura and Odriozola Leticia, Proteomic Analysis of Liver Diseases: Molecular Mechanisms and Biomarker Discovery, Mini-Reviews in Medicinal Chemistry 2008; 8 (1) . https://dx.doi.org/10.2174/138955708783331595
DOI https://dx.doi.org/10.2174/138955708783331595 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecule of the Month
Current Topics in Medicinal Chemistry Coenzyme Q10 Reduction with Statins: Another Pleiotropic Effect
Current Drug Therapy Small Molecule Antagonists of the Chemokine Receptor CCR5
Current Topics in Medicinal Chemistry Refined Purification of Large Amounts of Rat cvHsp/HspB7 and Partial Biological Characterization In Vitro
Protein & Peptide Letters Cancer Stem Cells: A Novel Paradigm for Cancer Prevention and Treatment
Mini-Reviews in Medicinal Chemistry Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
Current Pharmaceutical Design Flavonoids for Allergic Diseases: Present Evidence and Future Perspective
Current Pharmaceutical Design Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases
Current Medicinal Chemistry The Relationship Between HIV Infection and Cardiovascular Disease
Current Cardiology Reviews Patent Selections
Recent Patents on Cardiovascular Drug Discovery Pain and Obesity in the Older Adult
Current Pharmaceutical Design Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Ionic Liquids, Microextraction Methods and Capillary Electrophoresis in Biomedical Research
Current Pharmaceutical Analysis Editorial [Hot Topic Biomarkers, Molecular Imaging, and Novel Therapies of Cancer]
Current Molecular Medicine Secondary Hypertension: The Ways of Management
Current Vascular Pharmacology From Early Origins. When and Why does Asthma Develop?
Current Pediatric Reviews The Antioxidant Response as a Drug Target in Diabetic Neuropathy
Current Drug Targets Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Streptokinase: An Efficient Enzyme in Cardiac Medicine
Protein & Peptide Letters Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued)